Azenta (NASDAQ:AZTA) Stock Price Expected to Rise, Needham & Company LLC Analyst Says

Azenta (NASDAQ:AZTA) had its target price hoisted by analysts at Needham & Company LLC from $37.00 to $57.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC‘s price objective would indicate a potential upside of 16.56% from the stock’s current price.

A number of other equities research analysts have also issued reports on AZTA. Weiss Ratings raised shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 26th. Wall Street Zen cut shares of Azenta from a “buy” rating to a “hold” rating in a research note on Sunday, October 18th. Finally, Jefferies Financial Group raised their target price on shares of Azenta from $44.00 to $52.00 and gave the company a “buy” rating in a research note on Wednesday. Four analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $47.60.

Azenta Stock Up 20.8%

NASDAQ AZTA opened at $48.90 on Wednesday. The firm has a market cap of $2.14 billion, a price-to-earnings ratio of -13.51 and a beta of 1.47. The business has a 50-day moving average price of $35.98 and a 200-day moving average price of $28.51. Azenta has a twelve month low of $15.93 and a twelve month high of $50.06.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, November 10th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.17. Azenta had a positive return on equity of 1.37% and a negative net margin of 26.86%. The firm had revenue of $167.09 million during the quarter, compared to analysts’ expectations of $160.16 million.

Institutional Trading of Azenta

Several hedge funds have recently made changes to their positions in the business. Green Alpha Advisors LLC grew its position in Azenta by 3.5% in the third quarter. Green Alpha Advisors LLC now owns 9,187 shares of the company’s stock worth $321,000 after acquiring an additional 313 shares in the last quarter. Global Retirement Partners LLC raised its position in Azenta by 82.3% during the third quarter. Global Retirement Partners LLC now owns 771 shares of the company’s stock valued at $27,000 after purchasing an additional 348 shares during the period. Allworth Financial LP lifted its stake in shares of Azenta by 27.9% in the 3rd quarter. Allworth Financial LP now owns 2,421 shares of the company’s stock valued at $84,000 after purchasing an additional 528 shares during the last quarter. Illinois Municipal Retirement Fund lifted its stake in shares of Azenta by 2.8% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 22,864 shares of the company’s stock valued at $798,000 after purchasing an additional 620 shares during the last quarter. Finally, Heritage Family Offices LLP bought a new stake in shares of Azenta in the 3rd quarter valued at approximately $31,000. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Latest Azenta News

These are some of the AZTA news items that stood out recently:

• Positive Sentiment: Better FY2027 outlook: The company forecast revenue of $648 million to $660 million, above the $632.4 million consensus, with organic growth of 3%–5% after 2% in FY2026. It also expects adjusted EBITDA margin to expand by roughly 200–250 basis points, signaling improving business momentum. Azenta FY2026 results and FY2027 outlook
• Positive Sentiment: Buyback support: Azenta repurchased 4.4 million shares for $118.2 million in FY2026 and ended the year with $506 million in cash and marketable securities, providing financial flexibility and supporting per-share value. Azenta share repurchases and outlook
• Negative Sentiment: Legal overhang: Rosen Law Firm announced an investigation into possible securities claims alleging Azenta may have provided materially misleading business information. The claims are allegations, not findings, but could add uncertainty for investors. Securities class action investigation announcement

Azenta Company Profile

Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.